Viewing Study NCT03963193


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-31 @ 4:18 PM
Study NCT ID: NCT03963193
Status: UNKNOWN
Last Update Posted: 2019-05-24
First Post: 2019-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module